Nurses' Health Study

Nurses' Health Study

The Nurses' Health Study began as a large prospective cohort investigation enrolling female registered nurses to examine determinants of chronic disease and women's health. It linked repeated questionnaires, biomarker assays, and follow-up of morbidity and mortality to generate evidence on diet, lifestyle, and pharmacologic exposures related to outcomes such as cardiovascular disease, cancer, and diabetes. Investigators affiliated with institutions including Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health, and affiliated hospitals applied methods from observational epidemiology to address preventive medicine questions relevant to clinicians and policymakers.

Overview

The initial cohort recruited participants from professional organizations such as the American Nurses Association and used postal questionnaires similar to methods in the Framingham Heart Study and the British Doctors Study. Subsequent expansions paralleled cohort efforts like the Health Professionals Follow-up Study and collaborations with consortia including the Women's Health Initiative and the International Agency for Research on Cancer. Leadership over time involved investigators connected to institutions such as Massachusetts General Hospital, Johns Hopkins Hospital, and research networks at Columbia University. The cohorts yielded longitudinal data on exposures including smoking, hormone use, diet, physical activity, and medications such as aspirin and statins, and outcomes including incidence of coronary artery disease, multiple cancer types, and type 2 diabetes mellitus.

Study Design and Methods

Design features mirrored classical cohort frameworks used by teams at University of Oxford and the National Institutes of Health. Enrollment targeted licensed nurses from state boards and professional registries, producing well-characterized participants similar in concept to samples from Salk Institute-linked studies of health. Data collection relied on periodic mailed or electronic questionnaires, linkage to national death indices used by Centers for Disease Control and Prevention, and validation substudies using medical records from institutions such as Mayo Clinic. Dietary assessments used food frequency questionnaires adapted from methods developed at Harvard School of Public Health and calibrated against biomarkers measured in laboratories collaborating with Broad Institute and academic cores. Nested case–control analyses, genome-wide association studies in partnership with groups at Wellcome Trust and University of Cambridge, and randomized nested trials for interventions such as aspirin chemoprevention were combined with pharmacoepidemiologic techniques refined in cohorts like the Rotterdam Study.

Major Findings and Contributions

Analyses informed landmark associations that reshaped preventive cardiology and oncology. Work on smoking and cardiovascular risk echoed earlier seminal results from the Royal College of Physicians reports and linked smoking to multiple cancers reported by researchers at Memorial Sloan Kettering Cancer Center. Investigations of postmenopausal hormone therapy influenced reinterpretation of results from the Women's Health Initiative randomized trials and regulatory decisions involving agencies like the Food and Drug Administration. Nutritional epidemiology findings influenced dietary guidance promulgated by bodies such as the American Heart Association and drew on analytic approaches used in the Nurses' Health Study II and comparative cohorts like the Framingham Heart Study. Studies of aspirin and colorectal cancer incidence contributed evidence considered by panels convened by World Health Organization advisors and cancer institutes including the National Cancer Institute. Research on body mass index and diabetes paralleled population studies from Imperial College London and informed obesity management work at clinics such as Cleveland Clinic. Genetic and biomarker results integrated with projects at Broad Institute and consortia including dbGaP to advance understanding of gene–environment interplay.

Criticisms and Limitations

Critiques paralleled those raised against major observational cohorts such as potential residual confounding noted in debates around results from the Framingham Heart Study and the Health Professionals Follow-up Study. Concerns included selection bias due to enrollment of predominantly white, female, licensed professionals, limiting generalizability compared to population-representative surveys conducted by National Center for Health Statistics; measurement error in self-reported diet and activity similar to issues highlighted in work from University of Cambridge groups; and the potential for time-varying confounding requiring advanced methods developed by statisticians at Stanford University and University of California, Berkeley. Debates over causal inference invoked methodologies promoted by researchers at Harvard Law School-adjacent policy groups and biostatistics units linked to Johns Hopkins Bloomberg School of Public Health.

Legacy and Ongoing Research

The program spawned successor efforts and collaborations across institutions such as Massachusetts Institute of Technology researchers working on molecular epidemiology and consortia with the International Agency for Research on Cancer. It trained investigators who moved to leadership posts at centers including Yale School of Medicine, University of Pennsylvania, and University of Michigan. Continuing waves of follow-up, integration of genomics and metabolomics in partnership with the Broad Institute and biobanking efforts akin to those at UK Biobank, and linkage to electronic health records used by systems such as Kaiser Permanente sustain research on aging, multimorbidity, and preventive strategies. Policy and guideline impacts reverberate through organizations like the American College of Cardiology and the American Cancer Society. The study's datasets continue to support replications, pooled analyses with global cohorts such as the European Prospective Investigation into Cancer and Nutrition, and methodological innovations in longitudinal epidemiology.

Category:Epidemiological studies